The ensuing analysis revealed a noteworthy positive correlation between the expression levels of ALKBH7 and APNG (Figure 4A), which provided potential targets for further investigation into the underlying mechanisms driving glioblastoma progression and therapeutic responsiveness. Here, ALKBH7 is linked to glioblastoma.